Finding safe antiarrhythmic drugs for people with heart failure is an active area of study.

His primary research focus is the clinical pharmacology of antiarrhythmic drugs.

There are many different types of antiarrhythmic drugs.

Prajmaline has been indicated in the treatment of certain disorders where other antiarrhythmic drugs were not effective.

If antiarrhythmic drugs are not used after cardioversion, the heart may be at greater risk of going back into a fast heart rate.

There seems to be a synergistic effect between these electrolyte disorders and therapy with class 1a antiarrhythmic drugs.

He became interested in experimental cardiac arrhythmia and antiarrhythmic drugs, area rather unexplored at that time.

Data exist for several antiarrhythmic drugs.

Additional drugs to help prevent heart rhythm problems from recurring (antiarrhythmic drugs) may also be given before and after the procedure.

In other words, it is a tendency of antiarrhythmic drugs to facilitate emergence of new arrhythmias.

The electrocardiogram can fluctuate over time, depending on the autonomic balance and the administration of antiarrhythmic drugs.

Numerous other antiarrhythmic drugs may be effective if the more commonly used medications have not worked; these include flecainide or amiodarone.

Thus, some antiarrhythmic drugs associated with increased mortality can reduce HRV.

Torsades de pointes is the prototype of the new ventricular tachyarrhythmias provoked by antiarrhythmic drugs.

Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardium.

Younger patients with normal cardiac anatomy and function have the highest probability of maintaining normal rhythm while taking antiarrhythmic drugs.

Antiarrhythmic drugs

Some antiarrhythmic drugs, like amiodarone or sotalol work by getting a pharmacological QT prolongation.

Antiarrhythmic Drugs: A Practical Guide.

Further, calcium channel blockers (verapamil) and antiarrhythmic drugs maybe used as an adjunct therapy to β-blockers in symptomatic children.

Due to the irregular rhythm occurring in the atria, targeting them with antiarrhythmic drugs without affecting the ventricles would provide a desirable outcome.

This essentially limits the choice of antiarrhythmic drugs to class III agents in a large majority of patients with previous cardiac arrest.

All types of bradyarrhythmia and tachyarrhythmia, whether supraventricular or ventricular, can be worsened or provoked by antiarrhythmic drugs.

The result of their cooperation formed the basis of 'Vaughan Williams Classification' of antiarrhythmic drugs.

Experimental Cardiac Arrhythmias and Antiarrhythmic Drugs.